Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Disruption of EGFR-SAR1 interaction for cancer treatment

US Patent 10663465 · Granted May 26, 2020

Assignee

Inventors

View full patent text on Google Patents →